P2
General Information
DRACP ID DRACP01087
Peptide Name P2
Sequence KWKLFKKIGIGKFLHSATTF
Sequence Length 20
UniProt ID Not available
PubChem CID Not available
Origin Ceropin A-Magainin 2
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
NCI-H128 | Lung small cell carcinoma; Small cell lung cancer | Carcinoma | IC50=37.9 µM | MTT assay | 72 h | 1 |
NCI-H146 | Lung small cell carcinoma; Small cell lung cancer | Carcinoma | IC50=47.7 µM | MTT assay | 72 h | 1 |
NCI-H69 | Lung small cell carcinoma; Small cell lung cancer | Carcinoma | IC50=36.2 µM | MTT assay | 72 h | 1 |
Hemolytic Activity Human red blood cells: hemolysis 0.2%(50 μg/mL); hemolysis 1%(100 μg/mL)
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C116H180N28O24
Absent amino acids CDEMNPQRVY
Common amino acids K
Mass 268996
Pl 11.4
Basic residues 6
Acidic residues 0
Hydrophobic residues 9
Net charge 6
Boman Index -631
Hydrophobicity 1
Aliphatic Index 83
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 289.47
Polar residues 5
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 9352466
Title Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 15 and cecropin A-melittin hybrid peptides
Doi 10.1111/j.1399-3011.1997.tb01469.x
Year 1997
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available